The P-MAPA immunomodulator partially prevents apoptosis induced by Zika virus infection in THP-1 cells.
CONCLUSIONS: Our study reveals that P-MAPA seems to be a satisfactory alternative to inhibits the effects of Zika virus infection in mammalian cells.
PMID: 32484769 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Lima MC, Azevedo EAN, de Morais CNL, de Sousa LIO, Carvalho BM, da Silva IN, Franca RFO Tags: Curr Pharm Biotechnol Source Type: research
More News: Biotechnology | Brain | Guillain-Barr Syndrome | Neurology | Outbreaks | Pathology | Study | Zika Virus